Research and development of anti-infective drugs
Nosopharm has raised €2.4M across 1 funding round from 3 investors, most recently a Early VC round in Nov 2020. Based in Nimes, France; founded 2009; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-01 | Early VC |
| €2.4M |
| Alto Invest,Auriga Partners,Kreaxi |
| View deal → |
